X-136209951-G-C

Variant summary

Our verdict is Benign. Variant got -11 ACMG points: 0P and 11B. BP4_ModerateBP6BS1BS2

The NM_001159699.2(FHL1):ā€‹c.817G>Cā€‹(p.Val273Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000356 in 1,208,774 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 14 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 10/14 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: š‘“ 0.000045 ( 0 hom., 0 hem., cov: 22)
Exomes š‘“: 0.000035 ( 0 hom. 14 hem. )

Consequence

FHL1
NM_001159699.2 missense

Scores

2
12

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:1

Conservation

PhyloP100: 1.21
Variant links:
Genes affected
FHL1 (HGNC:3702): (four and a half LIM domains 1) This gene encodes a member of the four-and-a-half-LIM-only protein family. Family members contain two highly conserved, tandemly arranged, zinc finger domains with four highly conserved cysteines binding a zinc atom in each zinc finger. Expression of these family members occurs in a cell- and tissue-specific mode and these proteins are involved in many cellular processes. Mutations in this gene have been found in patients with Emery-Dreifuss muscular dystrophy. Multiple alternately spliced transcript variants which encode different protein isoforms have been described.[provided by RefSeq, Nov 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -11 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.16958019).
BP6
Variant X-136209951-G-C is Benign according to our data. Variant chrX-136209951-G-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 838540.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=1, Uncertain_significance=2}. Variant chrX-136209951-G-C is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0000452 (5/110563) while in subpopulation NFE AF= 0.0000945 (5/52906). AF 95% confidence interval is 0.0000371. There are 0 homozygotes in gnomad4. There are 0 alleles in male gnomad4 subpopulation. Median coverage is 22. This position pass quality control queck.
BS2
High Hemizygotes in GnomAdExome4 at 14 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
FHL1NM_001159699.2 linkuse as main transcriptc.817G>C p.Val273Leu missense_variant 6/6 ENST00000370683.6 NP_001153171.1 Q13642-5
FHL1NM_001159702.3 linkuse as main transcriptc.969G>C p.Pro323Pro synonymous_variant 8/8 ENST00000394155.8 NP_001153174.1 Q13642-2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
FHL1ENST00000370683.6 linkuse as main transcriptc.817G>C p.Val273Leu missense_variant 6/61 NM_001159699.2 ENSP00000359717.1 Q13642-5
FHL1ENST00000394155.8 linkuse as main transcriptc.969G>C p.Pro323Pro synonymous_variant 8/85 NM_001159702.3 ENSP00000377710.2 Q13642-2

Frequencies

GnomAD3 genomes
AF:
0.0000452
AC:
5
AN:
110563
Hom.:
0
Cov.:
22
AF XY:
0.00
AC XY:
0
AN XY:
32807
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000945
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000436
AC:
8
AN:
183526
Hom.:
0
AF XY:
0.0000589
AC XY:
4
AN XY:
67954
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000109
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000366
Gnomad OTH exome
AF:
0.000441
GnomAD4 exome
AF:
0.0000346
AC:
38
AN:
1098211
Hom.:
0
Cov.:
33
AF XY:
0.0000385
AC XY:
14
AN XY:
363565
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.000114
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000392
Gnomad4 OTH exome
AF:
0.0000217
GnomAD4 genome
AF:
0.0000452
AC:
5
AN:
110563
Hom.:
0
Cov.:
22
AF XY:
0.00
AC XY:
0
AN XY:
32807
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000945
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000868
Hom.:
1
Bravo
AF:
0.0000491
ExAC
AF:
0.0000247
AC:
3
EpiCase
AF:
0.00
EpiControl
AF:
0.0000593

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

X-linked myopathy with postural muscle atrophy Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 15, 2024This sequence change replaces valine, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 257 of the FHL1 protein (p.Val257Leu). This variant is present in population databases (rs190006104, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with FHL1-related conditions. ClinVar contains an entry for this variant (Variation ID: 838540). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available". The leucine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsFeb 24, 2023The p.V257L variant (also known as c.769G>C), located in coding exon 5 of the FHL1 gene, results from a G to C substitution at nucleotide position 769. The valine at codon 257 is replaced by leucine, an amino acid with highly similar properties. Based on data from gnomAD, the C allele has an overall frequency of <0.01% (8/183526) total alleles studied, with 4 hemizygote(s) observed. The highest observed frequency was 0.01% (3/27431) of Latino alleles. This amino acid position is poorly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
not provided Benign:1
Likely benign, criteria provided, single submitterclinical testingGeneDxNov 08, 2019- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.0035
T
BayesDel_noAF
Uncertain
-0.030
CADD
Benign
14
DANN
Benign
0.80
DEOGEN2
Benign
0.20
.;.;.;.;.;.;.;.;T;.
FATHMM_MKL
Benign
0.61
D
LIST_S2
Benign
0.86
.;.;.;.;.;D;D;D;T;.
M_CAP
Benign
0.014
T
MetaRNN
Benign
0.14
T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.83
T
PROVEAN
Benign
-0.85
.;N;.;N;N;N;N;N;N;.
REVEL
Uncertain
0.34
Sift
Benign
0.88
.;T;.;T;T;T;T;T;T;.
Sift4G
Benign
0.67
T;T;T;T;T;T;T;T;T;T
Vest4
0.16
MutPred
0.38
.;.;.;.;.;.;Loss of catalytic residue at V286 (P = 0.0428);.;.;.;
MVP
0.84
ClinPred
0.018
T
GERP RS
-0.74

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs190006104; hg19: chrX-135292110; API